Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara–Vectored Ebola Vaccines at 1 Year

Архивировано 04.10.2021: winslow-2017.pdf

Источник: Winslow R. L., Milligan I. D., Voysey M., et al. Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara–Vectored Ebola Vaccines at 1 Year. JAMA, 2017, 317(10):1075–1077

We report the 1-year data for the study of the Ad26.ZEBOV and MVA-BN-Filo vaccines,1 the longest duration follow-up for any heterologous primary and booster Ebola vaccine schedule to our knowledge.